Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothKoschmieder, S ; Mughal, T I ; Hasselbalch, H C ; Barosi, G ; Valent, P ; Kiladjian, J-J ; Jeryczynski, G ; Gisslinger, H ; Jutzi, J S ; Pahl, H L ; Hehlmann, R ; Maria Vannucchi, A ; Cervantes, F ; Silver, R T ; Barbui, TLeukemia, 2016-05, Vol.30 (5), p.1018-1024 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosisHarrison, C N ; Vannucchi, A M ; Kiladjian, J-J ; Al-Ali, H K ; Gisslinger, H ; Knoops, L ; Cervantes, F ; Jones, M M ; Sun, K ; McQuitty, M ; Stalbovskaya, V ; Gopalakrishna, P ; Barbui, TLeukemia, 2016-08, Vol.30 (8), p.1701-1707 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasmsTefferi, A ; Thiele, J ; Vannucchi, A M ; Barbui, TLeukemia, 2014-07, Vol.28 (7), p.1407-1413 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patientsTefferi, A ; Guglielmelli, P ; Lasho, T L ; Rotunno, G ; Finke, C ; Mannarelli, C ; Belachew, A A ; Pancrazzi, A ; Wassie, E A ; Ketterling, R P ; Hanson, C A ; Pardanani, A ; Vannucchi, A MLeukemia, 2014-07, Vol.28 (7), p.1494-1500 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Classification and Personalized Prognosis in Myeloproliferative NeoplasmsGrinfeld, Jacob ; Nangalia, Jyoti ; Baxter, E. Joanna ; Wedge, David C ; Angelopoulos, Nicos ; Cantrill, Robert ; Godfrey, Anna L ; Papaemmanuil, Elli ; Gundem, Gunes ; MacLean, Cathy ; Cook, Julia ; O’Neil, Laura ; O’Meara, Sarah ; Teague, Jon W ; Butler, Adam P ; Massie, Charlie E ; Williams, Nicholas ; Nice, Francesca L ; Andersen, Christen L ; Hasselbalch, Hans C ; Guglielmelli, Paola ; McMullin, Mary F ; Vannucchi, Alessandro M ; Harrison, Claire N ; Gerstung, Moritz ; Green, Anthony R ; Campbell, Peter JThe New England journal of medicine, 2018-10, Vol.379 (15), p.1416-1430 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working groupKröger, N M ; Deeg, J H ; Olavarria, E ; Niederwieser, D ; Bacigalupo, A ; Barbui, T ; Rambaldi, A ; Mesa, R ; Tefferi, A ; Griesshammer, M ; Gupta, V ; Harrison, C ; Alchalby, H ; Vannucchi, A M ; Cervantes, F ; Robin, M ; Ditschkowski, M ; Fauble, V ; McLornan, D ; Ballen, K ; Popat, U R ; Passamonti, F ; Rondelli, D ; Barosi, GLeukemia, 2015-11, Vol.29 (11), p.2126-2133 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international studyTefferi, A ; Rumi, E ; Finazzi, G ; Gisslinger, H ; Vannucchi, A M ; Rodeghiero, F ; Randi, M L ; Vaidya, R ; Cazzola, M ; Rambaldi, A ; Gisslinger, B ; Pieri, L ; Ruggeri, M ; Bertozzi, I ; Sulai, N H ; Casetti, I ; Carobbio, A ; Jeryczynski, G ; Larson, D R ; Müllauer, L ; Pardanani, A ; Thiele, J ; Passamonti, F ; Barbui, TLeukemia, 2013-09, Vol.27 (9), p.1874-1881 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisTEFFERI, A ; LASHO, T. L ; MAI, M ; MCCLURE, R. F ; GILLILAND, D. G ; LEVINE, R. L ; PARDANANI, A ; VANNUCCHI, A. M ; ABDEL-WAHAB, O ; GUGLIELMELLI, P ; PATEL, J ; CARAMAZZA, D ; PIERI, L ; FINKE, C. M ; KILPIVAARA, O ; WADLEIGH, MLeukemia, 2010-07, Vol.24 (7), p.1302-1309 [Periódico revisado por pares]Avenel, NJ: Nature Publishing GroupTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsGuglielmelli, P ; Lasho, T L ; Rotunno, G ; Score, J ; Mannarelli, C ; Pancrazzi, A ; Biamonte, F ; Pardanani, A ; Zoi, K ; Reiter, A ; Duncombe, A ; Fanelli, T ; Pietra, D ; Rumi, E ; Finke, C ; Gangat, N ; Ketterling, R P ; Knudson, R A ; Hanson, C A ; Bosi, A ; Pereira, A ; Manfredini, R ; Cervantes, F ; Barosi, G ; Cazzola, M ; Cross, N C P ; Vannucchi, A M ; Tefferi, ALeukemia, 2014-09, Vol.28 (9), p.1804-1810 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisalVannucchi, A M ; Antonioli, E ; Guglielmelli, P ; Pardanani, A ; Tefferi, ALeukemia, 2008-07, Vol.22 (7), p.1299-1307 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |